EAM Investors, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$548,281
-53.1%
212,512
-21.4%
0.11%
-50.9%
Q2 2023$1,168,210
+18.0%
270,419
+149.9%
0.22%
+45.0%
Q1 2021$990,000
-11.2%
108,232
-1.6%
0.15%
-18.6%
Q4 2020$1,115,000109,9850.18%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders